Beruflich Dokumente
Kultur Dokumente
PREPARATION:
I. Read and study the Memo to Dr. Creator with attachments.
II. You will be assigned a role as either Dr. Creator or Mr.
Owens. In your role as a founder of Bodacious Studios, be
prepared to critique the Summary of Proposed Terms and
develop a "shopping list" of changes you would want in that
term sheet. Our session together will involve a mock
discussion among all of the session participants in their roles
as founders of Bodacious Studios (one-half of the participants
in the role of Dr. Creator and one-half in the role of Mr.
Owens).
MEMORANDUM
FROM: C. E. Owens
venture capitalists that appear to be quite interested, one of whom tendered the
financing.
This confidential document and its contents are for internal management use
and may not be reproduced, used or disclosed without the prior written
approval of Bodacious Studios, Inc.
Any relation or similarity between the fictional persons, places and situations
contained herein and real persons, places and situations are unintentional and
are expressly disclaimed.
-1-
OVERVIEW
-2-
“Crash and Infirm” How to operate a successful
drugstore or old age home
TOTAL $4,300,000
-3-
shares as follows: Dr. Creator: $100,000
CE Owens: $200,000.
The first three phases are anticipated to take one year from funding.
FINANCIAL ASPECTS
Projections.
The following are projections of cash flow and net income for BSI,
based upon a conservative scenario.
BODACIOUS STUDIOS, INC.
SUMMARY OF PROJECTIONS
(in 000’s)
Yr l Yr 2 Yr 3 Yr 4 Yr 5 Yr 6 Yr 7
-4-
MANAGEMENT
Mr. Owens will oversee all business and financial activities of BSI.
Dr. Creator will plan the company’s core technology and will work
with the production team to implement the core technology and create the
company’s products.
-5-
SUMMARY OF PROPOSED TERMS OF ISSUANCE AND SALE OF
PREFERRED STOCK
Introduction
A. Amount: $4,000,000.00
-1-
rata in any further dividends paid.
-2-
will be the Original Purchase Price.
The conversion price will be subject
to adjustment as provided in
paragraph (6) below.
-3-
Preferred Stock. Election of
Directors will be as described under
“Board Representation and
Meetings” below.
-4-
Company and an annual budget.
The obligation of the Company to
furnish monthly financial
statements will terminate upon a
public offering of the Company’s
Common Stock. Inspection rights
(of the subject matters described in
California Corporation Code
Sections 1600, 1601 and 1602 and
other relevant subject materials)
related to the Company will be
available to any investor who has
purchased at least $250,000 of
Preferred Stock and who still holds
any amount of Preferred Stock or
Common Stock issued upon
conversion of any Preferred Stock.
-5-
(other than on Form S-3) under
these demand right provisions.
-6-
(5) Other Registration Provisions.
Other provisions will be contained
in the Stock Purchase Agreement
with respect to registration rights as
are reasonable, including cross-
indemnification, the Company’s
ability to delay the filing of a
demand registration for a period of
at least ninety days, the agreement
by purchasers of the Preferred
Stock if requested by the
underwriter in a public offering not
to sell any Common Stock which
they held prior to that offering for a
period of 180 days following the
effective date of the Registration
Statement of such offering, the
period of time in which the
Registration Statement will be kept
effective, underwriting
arrangements and the like.
-7-
the number of options given to
other outside directors), will be
reimbursed for reasonable expenses
incurred in attending meetings of
the Board of Directors and will be
Indemnified for their non-negligent
acts to the extent permitted under
applicable law.
-8-
Founders will be subject to Stock
Restriction Agreements providing
for vesting as follows: 25% vests
on each of the first, second, third
and fourth anniversaries of the
closing of the placement described
in this Memorandum. Upon the
death or permanent disability of a
Founder, no additional stock will
vest. Until the completion of the
Company’s initial public offering,
the Company will have a right of
first refusal as to the sale of any
vested stock of any Founder and co-
sale rights on any sale of shares by
a Founder. Unvested stock may not
be transferred.
-9-
approved by the Board of Directors.
-10-